• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

At the Heart of Treating Kawasaki Disease: The Search for New Approaches to Prevent Coronary Artery Aneurysms.

作者信息

Du Yan, Lee Pui Y

机构信息

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, and Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

出版信息

Arthritis Rheumatol. 2023 Feb;75(2):149-152. doi: 10.1002/art.42346. Epub 2022 Dec 16.

DOI:10.1002/art.42346
PMID:36066560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9892198/
Abstract
摘要

相似文献

1
At the Heart of Treating Kawasaki Disease: The Search for New Approaches to Prevent Coronary Artery Aneurysms.治疗川崎病的核心：寻找预防冠状动脉瘤的新方法。
Arthritis Rheumatol. 2023 Feb;75(2):149-152. doi: 10.1002/art.42346. Epub 2022 Dec 16.
2
Giant coronary artery aneurysms in Kawasaki disease.川崎病中的巨大冠状动脉瘤
Acta Cardiol. 2024 Apr;79(2):242-243. doi: 10.1080/00015385.2023.2272551. Epub 2023 Oct 31.
3
[Effect of immunoglobulin in the prevention of coronary artery aneurysms in Kawasaki disease].[免疫球蛋白在预防川崎病冠状动脉瘤中的作用]
Tunis Med. 2009 Mar;87(3):228-9.
4
Predicting coronary aneurysms in Kawasaki disease.预测川崎病中的冠状动脉瘤
Am J Cardiol. 1998 May 1;81(9):1162-4. doi: 10.1016/s0002-9149(98)00115-5.
5
A rare cause of coronary artery aneurysms with possible underlying Kawasaki disease.一种罕见的冠状动脉瘤病因，可能存在潜在的川崎病。
J Int Med Res. 2020 Jan;48(1):300060519862947. doi: 10.1177/0300060519862947. Epub 2019 Jul 25.
6
Coronary artery bypass for multiple coronary artery aneurysms due to Kawasaki disease.川崎病所致多发性冠状动脉瘤的冠状动脉搭桥术
J Card Surg. 2018 Oct;33(10):651-652. doi: 10.1111/jocs.13818. Epub 2018 Sep 10.
7
Giant triple coronary artery aneurysms from incomplete Kawasaki disease.不完全川崎病所致巨大冠状动脉瘤三联征
BMJ Case Rep. 2015 Apr 15;2015:bcr2015210110. doi: 10.1136/bcr-2015-210110.
8
Atypical coronary artery aneurysms due to Kawasaki disease in Noonan syndrome with a novel PTPN11 mutation.患有新型PTPN11突变的努南综合征患者因川崎病导致的非典型冠状动脉瘤
Cardiol Young. 2019 Feb;29(2):228-230. doi: 10.1017/S1047951118001877. Epub 2018 Dec 4.
9
Ten-year evolution of giant coronary artery aneurysms secondary to Kawasaki disease.川崎病继发巨大冠状动脉瘤的十年演变
Cardiol J. 2016;23(5):513-514. doi: 10.5603/CJ.2016.0073.
10
Giant coronary artery aneurysms in Kawasaki disease: the cost of a missed diagnosis.川崎病中的巨大冠状动脉瘤：漏诊的代价。
Cardiol Young. 2013 Aug;23(4):608-9. doi: 10.1017/S1047951112002338.

本文引用的文献

1
Mechanistic Target of Rapamycin Inhibition Prevents Coronary Artery Remodeling in a Murine Model of Kawasaki Disease.雷帕霉素作用机制靶点抑制可预防川崎病小鼠模型中的冠状动脉重塑。
Arthritis Rheumatol. 2023 Feb;75(2):305-317. doi: 10.1002/art.42340. Epub 2022 Dec 20.
2
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease.2021年美国风湿病学会/血管炎基金会川崎病管理指南
Arthritis Care Res (Hoboken). 2022 Apr;74(4):538-548. doi: 10.1002/acr.24838. Epub 2022 Mar 7.
3
Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis.
在诊断时伴有冠状动脉瘤的川崎病患者中，辅助使用皮质类固醇激素的初级治疗与改善结局相关。
Arch Dis Child. 2021 Mar;106(3):247-252. doi: 10.1136/archdischild-2020-319810. Epub 2020 Sep 17.
4
Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis.川崎病合并冠状动脉瘤患儿的强化治疗。
Pediatrics. 2019 Jun;143(6). doi: 10.1542/peds.2018-3341. Epub 2019 May 2.
5
TNF and IL-1 Play Essential but Temporally Distinct Roles in Driving Cardiac Inflammation in a Murine Model of Kawasaki Disease.TNF 和 IL-1 在川崎病小鼠模型中驱动心脏炎症中发挥重要但时间上不同的作用。
J Immunol. 2019 Jun 1;202(11):3151-3160. doi: 10.4049/jimmunol.1801593. Epub 2019 Apr 17.
6
The metabolic regulator mTORC1 controls terminal myeloid differentiation.代谢调节因子mTORC1控制终末髓系分化。
Sci Immunol. 2017 May 26;2(11). doi: 10.1126/sciimmunol.aam6641.
7
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.川崎病的诊断、治疗和长期管理：美国心脏协会发布的一份面向医疗保健专业人员的科学声明。
Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29.
8
mTOR Signaling in Growth, Metabolism, and Disease.生长、代谢及疾病中的mTOR信号传导
Cell. 2017 Mar 9;168(6):960-976. doi: 10.1016/j.cell.2017.02.004.
9
mTOR inhibitors in pediatric kidney transplantation.儿科肾移植中的mTOR抑制剂
Pediatr Nephrol. 2014 Jul;29(7):1119-29. doi: 10.1007/s00467-013-2505-9. Epub 2013 Jun 7.
10
Regulation and function of mTOR signalling in T cell fate decisions.mTOR 信号在 T 细胞命运决定中的调控和功能。
Nat Rev Immunol. 2012 Apr 20;12(5):325-38. doi: 10.1038/nri3198.